Summit Therapeutics to raise funds for Duchenne and C diff drugs

05/03/2015

Summit Therapeutics to raise funds for Duchenne and C diff drugsAndrew McConaghie

UK biotech firm Summit Therapeutics is preparing a US share offer to raise funding for its research programmes.The Oxford-based company is already listed on London's AIM market, but will now... Read more

AbbVie swoops for Pharmacyclics in $21bn takeover

05/03/2015

AbbVie swoops for Pharmacyclics in $21bn takeoverAndrew McConaghie

Johnson & Johnson has missed out on acquiring its marketing partner Pharmacyclics after AbbVie snatched the company from under its nose with a $21 billion takeover.The acquisition of Pharmacyclics and... Read more

Opdivo cleared for lung cancer in record time

05/03/2015

Opdivo cleared for lung cancer in record timeStaff reporter

Bristol-Myers Squibb's Opdivo has been cleared in the US to treat lung cancer, a full three months ahead of the FDA's review deadline.The positive verdict by the agency gives PD-1... Read more

BMS keeps foot on immuno-oncology accelerator

04/03/2015

BMS keeps foot on immuno-oncology acceleratorStaff reporter

A filing for anti-PD-1 drug Opdivo in lung cancer, plus three new licensing and acquisition deals, shows Bristol-Myers Squibb (BMS) has no intention of slowing its immuno-oncology drive.The US FDA... Read more

Latest Press Releases from the Global Pharma Showcase

  • Press Release

    05/03/2015

    The Health Industry Summit, EXPO and Congress (tHIS) held in May in Shanghai announced further increases in size to reach 280,000sqm ahead...

    View full release
  • Press Release

    04/03/2015

     

     

    Adelphi Research UK has a strong heritage of providing robust market research in the healthcare sector. Established since 2000, they have extensive...

    View full release
  • Press Release

    04/03/2015

    New research reveals pharmaceutical and medical attitudes to ‘KOL’ terminology

    Nearly two-thirds (62%) of medical experts believe the pharmaceutical industry should replace the term Key Opinion Leader (KOL)1 – according to...

    View full release
  • Press Release

    02/03/2015

    Healthcare Partners’ second advisory board meeting will take place on Tuesday 12th May from 10-1pm at IMS Health...

    View full release
  • Press Release

    25/02/2015

    Washington, D.C. (February 25, 2015) — Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released a new report, “A Decade of Innovation in Rare Diseases,” to document the...

    View full release